HOME Top Market Reports Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

Respiratory Diagnostics Market by Product & Service (Instruments/Devices, Kits/Reagents), Test Type (Pulmonary Function Test, Imaging Test), Disease (TB, Lung Cancer, COPD), End User (Reference Laboratories, Physician Offices) - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: November 2016
Report Code: MD 4740

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The global respiratory diagnostics market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. In this report, the global market is broadly segmented by product and service, test type, disease, end user, and region.

On the basis of product and service, the instruments and devices segment is expected to account for the largest share of the market in 2016. This large share can be attributed to the continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care diagnosis.

The traditional diagnostic tests segment is expected to account for the largest share during the forecast period. The large share of this segment is primarily attributed to the quick turnaround time of these tests.

Furthermore, on the basis of disease, the tuberculosis segment is expected to dominate the market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels. On the other hand, the lung cancer segment is expected to grow at the highest CAGR during the forecast period. The growing disease burden and the need for diagnostic procedures are key factors driving the demand for respiratory diagnostics for lung cancer.

Based on end user, the hospital/clinical laboratories segment is expected to account for the largest share of the global market as well as this segment is witnessed the highest growth in the forecast period. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the market for hospital/clinical laboratories.

Factors such as increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are driving the growth of the global market. Emerging markets such as Asia-Pacific provide new growth opportunities for players in the market. On the other hand, rising healthcare costs and reimbursement concerns are the major factors restraining the growth of the market. In addition, lack of awareness and the presence of a large underdiagnosed and undertreated population are the major challenges in the market.

The respiratory diagnostics market is dominated by established players such as Philips Healthcare (Netherlands), Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Alere, Inc. (U.S.).

Stakeholders

  • Respiratory diagnostic device manufacturers and distributors
  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
  • Research institutes
  • Contract manufacturing organizations (CMOs)
  • Government associations
  • Market research and consulting firms

Scope of the Report

  • The market study doesn’t cover the market size in terms of volume
  • Some companies in this market are privately owned and their revenues are not available in the  public domain. Hence, revenue for those companies are not included in this report
  • Company developments not reported in the public domain are not included in this report

Respiratory Diagnostics Market

To know about the assumptions considered for the study, download the pdf brochure

Market Segmentation

This research report categorizes the respiratory diagnostics market on the basis of product and service, test type, end user, disease, and region.

Global Respiratory Diagnostics Market, by Product and Service

  • Instruments and Devices
  • Assays and Reagents
  • Services and Software

 Global Respiratory Diagnostics Market, by Test Type

  • Traditional Diagnostic Tests
  • Mechanical Tests
  • Imaging Tests
  • Molecular Diagnostic Tests

 Global Respiratory Diagnostics Market, by Disease

  • Chronic Obstructive Pulmonary Disease
  • Lung Cancer
  • Asthma
  • Tuberculosis
  • Other Diseases

 Global Respiratory Diagnostics Market, by End User

  • Hospital/Clinical Laboratories
  • Physician Offices
  • Reference Laboratories
  • Other End Users

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Geographical Analysis

  • Further breakdown of the North American respiratory diagnostics market into the U.S. and Canada
  • Further breakdown of the APAC market into China, Japan, India, and Rest of Asia-Pacific
  • Further breakdown of the European market into Germany, France, the U.K., and Rest of Europe

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 15)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Respiratory Diagnostics Market, By Region
           1.3.3 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Market Size Estimation
    2.2 Market Breakdown and Data Triangulation
           2.2.1 Key Data From Secondary Sources
           2.2.2 Key Data From Primary Sources
                    2.2.2.1 Key Industry Insights
           2.2.3 Assumptions for the Study

3 Executive Summary (Page No. - 26)
    3.1 Conclusion

4 Premium Insights (Page No. - 30)
    4.1 Market Snapshot, 2016 vs 2021
    4.2 Market, By Test Type
    4.3 Market, By Region
    4.4 Market, By Product & Service
    4.5 Market, By End User
    4.6 Market, By Disease

5 Market Overview (Page No. - 34)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Rising Prevalence of Respiratory Diseases
                    5.2.1.1 High Prevalence of Tobacco Smoking
                    5.2.1.2 Changing Lifestyles
                    5.2.1.3 Urbanization and Growing Pollution Levels
           5.2.2 Rising Geriatric Population
           5.2.3 Technological Advancements
           5.2.4 Market Restraints
                    5.2.4.1 Reimbursement Concerns
                    5.2.4.2 Rising Healthcare Costs Limiting the Usage of Novel Respiratory Diagnostic Techniques
           5.2.5 Market Opportunities
                    5.2.5.1 Growing Demand for Home Care and Point-Of-Care Diagnostic Devices
                    5.2.5.2 High Growth Potential in Developing Asia-Pacific Countries
           5.2.6 Market Challenge
                    5.2.6.1 Lack of Awareness and Large Underdiagnosed and Undertreated Population

6 Respiratory Diagnostics Market, By Product and Service (Page No. - 42)
    6.1 Introduction
    6.2 Instruments & Devices
    6.3 Assays & Reagents
    6.4 Services & Software

7 Respiratory Diagnostics Market, By Test Type (Page No. - 47)
    7.1 Introduction
    7.2 Mechanical Tests
           7.2.1 Pulmonary Function Tests
                    7.2.1.1 Spirometry
                    7.2.1.2 Peak Flow Test
    7.3 OSA Diagnostic Tests
    7.4 Other Test Types
    7.5 Imaging Tests
           7.5.1 X-Ray
           7.5.2 Computed Tomography
           7.5.3 Magnetic Resonance Imaging (MRI)
           7.5.4 Positron Emission Tomography (PET)
           7.5.5 Other Imaging Tests
    7.6 Traditional Diagnostic Tests
           7.6.1 Immunodiagnostics
           7.6.2 Biochemical Characterization
           7.6.3 Microscopy
    7.7 Molecular Diagnostic Tests
           7.7.1 Pcr
           7.7.2 Nucleic Acid Amplification Test
           7.7.3 In Situ Hybridization
           7.7.4 DNA Sequencing & Next-Generation Sequencing (NGS)
           7.7.5 Microarrays
           7.7.6 Other Molecular Diagnostic Tests

8 Respiratory Diagnostics Market, By Disease (Page No. - 67)
    8.1 Introduction
    8.2 Tuberculosis
    8.3 Asthma
    8.4 Lung Cancer
    8.5 Chronic Obstructive Pulmonary Disease
    8.6 Other Respiratory Diseases

9 Respiratory Diagnostics Market, By End User (Page No. - 74)
    9.1 Introduction
    9.2 Hospital/Clinical Laboratories
    9.3 Reference Laboratories
    9.4 Physician Offices
    9.5 Other End Users

10 Respiratory Diagnostics Market, By Region (Page No. - 80)
     10.1 Introduction
     10.2 North America
     10.3 Europe
     10.4 Asia-Pacific
     10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 101)
     11.1 Overview
     11.2 Battle for Market Share: Product & Service Launches—Key Growth Strategy Adopted By Market Players
     11.3 Product & Service Launches
     11.4 Regulatory Approvals
     11.5 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts
     11.6 Acquisitions
     11.7 Expansions

12 Company Profiles (Page No. - 107)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Philips Healthcare
     12.3 Becton, Dickinson & Company
     12.4 Abbott Laboratories
     12.5 Thermo Fisher Scientific Inc.
     12.6 Biomιrieux
     12.7 Alere Inc.
     12.8 Bio-Rad Laboratories, Inc.
     12.9 Cosmed
     12.10 Seegene Inc.
     12.11 Sdi Diagnostics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 132)
     13.1 Insights of Industry Experts
     13.2 Discussion Guide
     13.3 Other Developments
     13.4 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.5 Introducing RT: Real-Time Market Intelligence
     13.6 Available Customizations
     13.7 Related Reports
     13.8 Author Details


List of Tables (83 Tables)

Table 1 Total Number of Deaths Associated With Respiratory Diseases, 2000 vs 2012
Table 2 Overweight Adult Population Statistics, By Country, 2000 vs 2014 (% of Total Adult Population)
Table 3 Global Market Size, By Product & Service, 2014–2021 (USD Million)
Table 4 Global Respiratory Diagnostic Instruments & Devices Market Size, By Region, 2014–2021 (USD Million)
Table 5 Global Respiratory Diagnostic Assays & Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 6 Global Respiratory Diagnostic Services & Software Market Size, By Region, 2014–2021 (USD Million)
Table 7 Market Size, By Test Type, 2014–2021 (USD Million)
Table 8 Market Size for Mechanical Tests, By Region, 2014–2021 (USD Million)
Table 9 Market Size for Mechanical Tests, By Type, 2014–2021 (USD Million)
Table 10 Pulmonary Function Tests Market Size, By Type, 2014–2021 (USD Million)
Table 11 Spirometry Tests Market Size, By Region, 2014–2021 (USD Million)
Table 12 Peak Flow Tests Market Size, By Region, 2014–2021 (USD Million)
Table 13 OSA Diagnostic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 14 Other Mechanical Tests Market Size, By Region, 2014–2021 (USD Million)
Table 15 Market Size for Imaging Tests, By Region, 2014–2021 (USD Million)
Table 16 Market Size for Imaging Tests, By Type, 2014–2021 (USD Million)
Table 17 X-Ray Tests Market Size, By Region, 2014–2021 (USD Million)
Table 18 CT Tests Market Size, By Region, 2014–2021 (USD Million)
Table 19 MRI Tests Market Size, By Region, 2014–2021 (USD Million)
Table 20 PET Tests Market Size, By Region, 2014–2021 (USD Million)
Table 21 Other Imaging Tests Market Size, By Region, 2014–2021 (USD Million)
Table 22 Respiratory Diagnostics Market Size for Traditional Diagnostic Tests, By Region, 2014–2021 (USD Million)
Table 23 Traditional Diagnostic Tests Market Size, By Type, 2014–2021 (USD Million)
Table 24 Immunodiagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 25 Biochemical Characterization Market Size, By Region, 2014–2021 (USD Million)
Table 26 Microscopy Market Size, By Region, 2014–2021 (USD Million)
Table 27 Respiratory Diagnostics Market Size for Molecular Diagnostic Tests, By Region, 2014–2021 (USD Million)
Table 28 Respiratory Diagnostics Market Size for Molecular Diagnostic Tests, By Type, 2014–2021 (USD Million)
Table 29 Pcr Tests Market Size, By Region, 2014–2021 (USD Million)
Table 30 Nucleic Acid Amplification Tests Market Size, By Region, 2014–2021 (USD Million)
Table 31 In Situ Hybridization Tests Market Size, By Region, 2014–2021 (USD Million)
Table 32 DNA Sequencing & NGS Market Size, By Region, 2014–2021 (USD Million)
Table 33 Microarrays Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other Molecular Diagnostic Tests Market Size, By Region, 2014–2021 (USD Million)
Table 35 Respiratory Diagnostics Market Size, By Disease, 2014–2021 (USD Million)
Table 36 Respiratory Diagnostics Market Size for Tuberculosis, By Region, 2014–2021 (USD Million)
Table 37 Respiratory Diagnostics Market Size for Asthma, By Region, 2014–2021 (USD Million)
Table 38 Respiratory Diagnostics Market Size for Lung Cancer, By Region, 2014–2021 (USD Million)
Table 39 Respiratory Diagnostics Market Size for Copd, By Region, 2014–2021 (USD Million)
Table 40 Respiratory Diagnostics Market Size for Other Diseases, By Region, 2014–2021 (USD Million)
Table 41 Respiratory Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 42 Respiratory Diagnostics Market Size for Hospital/Clinical Laboratories, By Region, 2014–2021 (USD Million)
Table 43 Respiratory Diagnostics Market Size for Reference Laboratories, By Region, 2014–2021 (USD Million)
Table 44 Respiratory Diagnostics Market Size for Physician Offices, By Region, 2014–2021 (USD Million)
Table 45 Respiratory Diagnostics Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 46 Respiratory Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 47 North America: Respiratory Diagnostics Market Size, By Products and Services, 2014–2021 (USD Million)
Table 48 North America: Respiratory Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 49 North America: Traditional Tests Market Size, By Type, 2014–2021 (USD Million)
Table 50 North America: Mechanical Tests Market Size, By Type, 2014–2021 (USD Million)
Table 51 North America: Imaging Tests Market Size, By Type, 2014–2021 (USD Million)
Table 52 North America: Molecular Diagnostic Tests Market Size, By Type, 2014–2021 (USD Million)
Table 53 North America: Respiratory Diagnostics Market Size, By Disease, 2014–2021 (USD Million)
Table 54 North America: Respiratory Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 55 Europe: Respiratory Diagnostics Market Size, By Products and Services, 2014–2021 (USD Million)
Table 56 Europe: Respiratory Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 57 Europe: Traditional Tests Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Mechanical Tests Market Size, By Type, 2014–2021 (USD Million)
Table 59 Europe: Imaging Tests Market Size, By Type, 2014–2021 (USD Million)
Table 60 Europe: Molecular Diagnostic Tests Market Size, By Type, 2014–2021 (USD Million)
Table 61 Europe: Respiratory Diagnostics Market Size, By Disease, 2014–2021 (USD Million)
Table 62 Europe: Respiratory Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 63 Asia-Pacific: Respiratory Diagnostics Market Size, By Products and Services, 2014–2021 (USD Million)
Table 64 Asia-Pacific: Respiratory Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 65 Asia-Pacific: Traditional Tests Market Size, By Type, 2014–2021 (USD Million)
Table 66 Asia-Pacific: Mechanical Tests Market Size, By Type, 2014–2021 (USD Million)
Table 67 Asia-Pacific: Imaging Tests Market Size, By Type, 2014–2021 (USD Million)
Table 68 Asia-Pacific: Molecular Diagnostic Tests Market Size, By Type, 2014–2021 (USD Million)
Table 69 Asia-Pacific: Respiratory Diagnostics Market Size, By Disease, 2014–2021 (USD Million)
Table 70 Asia-Pacific: Respiratory Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 71 RoW: Respiratory Diagnostics Market Size, By Products and Services, 2014–2021 (USD Million)
Table 72 RoW: Respiratory Diagnostics Market Size, By Test Type, 2014–2021 (USD Million)
Table 73 RoW: Traditional Tests Market Size, By Type, 2014–2021 (USD Million)
Table 74 RoW: Mechanical Tests Market Size, By Type, 2014–2021 (USD Million)
Table 75 RoW: Imaging Tests Market Size, By Type, 2014–2021 (USD Million)
Table 76 RoW: Molecular Diagnostic Tests Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoW: Respiratory Diagnostics Market Size, By Disease, 2014–2021 (USD Million)
Table 78 RoW: Respiratory Diagnostics Market Size, By End User, 2014–2021 (USD Million)
Table 79 Product & Service Launches, 2014–2016
Table 80 Regulatory Approvals, 2014–2016
Table 81 Agreements, Collaborations, Partnerships, Joint Ventures, and Contracts, 2014–2016
Table 82 Acquisitions, 2014–2016
Table 83 Expansions, 2014–2016


List of Figures (39 Figures)

Figure 1 Research Design
Figure 2 Respiratory Diagnostics Market: Top Down Approach
Figure 3 Respiratory Diagnostics Market: Bottom Up Approach
Figure 4 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 5 Market Data Triangulation Methodology
Figure 6 Respiratory Diagnostics Market Snapshot, 2016 vs 2021
Figure 7 Respiratory Diagnostics Market Size, By Products & Services, 2016 vs 2021
Figure 8 Respiratory Diagnostics Market Size, By Test Type, 2016 vs 2021
Figure 9 Respiratory Diagnostics Market Size, By End User, 2016 vs 2021
Figure 10 Respiratory Diagnostics Market Size, By Disease, 2016 vs 2021
Figure 11 Geographical Snapshot of the Respiratory Diagnostics Market
Figure 12 Increasing Prevalence of Respiratory Diseases, an Important Growth Driver
Figure 13 Mechanical Tests to Account for the Largest Market Share in 2016
Figure 14 Asia-Pacific to Grow at the Highest Rate During the Forecast Period
Figure 15 The Instruments and Devices Segment to Dominate the Respiratory Diagnostics Products & Services Market in 2016
Figure 16 Hospital/Clinical Laboratories, the Largest End Users of the Respiratory Diagnostics Market in 2016
Figure 17 The Tuberculosis Disease Segment to Dominate the Respiratory Diagnostics Disease Market in 2016
Figure 18 Respiratory Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Copd and Asthma Prevalence, By Country, 2014
Figure 20 Smoking Prevalence, By Country, 2010 (% of Total Population)
Figure 21 Global Geriatric Population, By Region
Figure 22 Instruments & Devices to Dominate the Respiratory Diagnostics Market in 2016
Figure 23 Traditional Diagnostic Tests to Dominate the Respiratory Diagnostics Market During the Forecast Period
Figure 24 Tuberculosis Segment to Dominate the Respiratory Diagnostics Market in 2016
Figure 25 Hospital/Clinical Laboratories to Dominate the Respiratory Diagnostics Market in 2016
Figure 26 Asia-Pacific Market Projected to Grow at the Highest Rate During the Forecast Period
Figure 27 North America: Respiratory Diagnostics Market Snapshot
Figure 28 Instruments/Devices Segment to Dominate the Respiratory Diagnostic Products and Services Market in North America
Figure 29 Asia-Pacific: Respiratory Diagnostics Market Snapshot
Figure 30 Companies Majorly Pursued the Strategy of Product & Service Launches Between 2014 and 2016
Figure 31 Geographic Revenue Mix of the Top Five Market Players
Figure 32 Company Snapshot: Philips Healthcare
Figure 33 Company Snapshot: Becton, Dickinson and Company
Figure 34 Company Snapshot: Abbott Laboratories
Figure 35 Company Snapshot: Thermo Fisher Scientific Inc.
Figure 36 Company Snapshot: Biomιrieux
Figure 37 Company Snapshot: Alere Inc.
Figure 38 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 39 Company Snapshot: Seegene Inc.

The global respiratory diagnostics market is projected to reach USD 7.45 Billion by 2021 from USD 5.24 Billion in 2016, at a CAGR of 7.3% from 2016 to 2021. In this report, the global market is broadly segmented by product and service, test type, disease, end user, and region.

Increasing prevalence of respiratory diseases, growing geriatric population, and technological advancements in respiratory diagnostic systems are the major factors driving the growth of the global market. On the other hand, rising healthcare costs (a major factor limiting the use of novel respiratory diagnostic techniques) and reimbursement concerns are the major factors restraining the growth of the market.

On the basis of product and service, the respiratory diagnostics market is segmented into instruments & devices, assays & reagents, and software & services. The instruments and devices segment is expected to account for the largest share of the market in 2016. The continuous requirement of diagnostic instruments and devices in laboratories, point-of-care, and home care is a major factor driving the uptake of instruments and devices.

On the basis of test type, the respiratory diagnostics market is broadly classified into mechanical tests, imaging tests, traditional diagnostic tests, and molecular diagnostic tests. In 2016, the traditional diagnostic tests segment is expected to account for the largest share of the market. The large share of this segment can be primarily attributed to the quick turnaround time of these tests.

On the basis of disease, the respiratory diagnostics market is segmented into asthma, chronic obstructive pulmonary disease, lung cancer, tuberculosis, and other diseases. The tuberculosis segment is expected to account for the largest share of the market in 2016. The large share of this segment can be primarily attributed to the increase in tobacco smoking and growing air pollution levels.

On the basis of end user, the market is categorized into hospital/clinical laboratories, reference laboratories, physician offices, and other end users (including blood banks, point-of-care testing, patient self-testing, home health agencies, nursing homes, and local public health laboratories). In 2016, the hospital/clinical laboratories segment is expected to account for the largest share of the global market. Most respiratory disease diagnostics are carried out in hospitals as they are complex in nature and require technologically advanced products; this is driving the market for hospital/clinical laboratories.

North America is expected to account for the largest share of the global respiratory diagnostics market in 2016, followed by Europe. The growth of the market in North America is majorly driven by the rising prevalence of respiratory diseases and growing geriatric population in the region. Other factors supporting the growth of this market include the presence of an advanced healthcare system and strong distribution channels for respiratory diagnostic products in North America.

The respiratory diagnostics market is dominated by established players such as Philips Healthcare (Netherlands), Becton, Dickinson and Company (U.S.), Abbott Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), and Alere, Inc. (U.S.).

Respiratory Diagnostics Market

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo